References
- Maggio L, ten Cate O, Chen HC, et al. Challenges to learning evidence-based medicine and educational approaches to meet these challenges: a qualitative study of selected EBM Curricula in U.S. and Canadian medical schools. Academic Medicine. 2016 [First published online July 21, 2015];91:101–106.
- Oude Rengerink K, Thangaratinam S, Barnfield, G, et al. How can we teach EBM in clinical practice? An analysis of barriers to implementation of on-the-job EBM teaching and learning. Med Teach. 2011;33(3):e125–30. doi: 10.3109/0142159X.2011.542520
- Zanaridah M, Norhayati M, Rosnani Z. Knowledge, attitude and practice of evidence-based medicine among primary care practitioners in Malaysia: a cross-sectional study. BMJ Open. 2021;11(6):e044372. doi: 10.1136/bmjopen-2020-044372
- Van Dijk N, Hooft L, Wieringa-de Waard M. What are the barriers to residentsʼ practicing evidence-based medicine? A systematic review. Acad Med. 2010;85(7):1163–1170. doi: 10.1097/ACM.0b013e3181d4152f
- Zwolsman S, van Dijk N, Te Pas E, et al. Barriers to the use of evidence-based medicine: knowledge and skills, attitude, and external factors. Perspect Med Educ. 2013;2(1):4–13. doi: 10.1007/s40037-013-0039-2
- Welink L, Roy K, Damoiseaux RAMJ, et al. Applying evidence-based medicine in general practice: a video-stimulated interview study on workplace-based observation. BMC Fam Pract. 2020;21(1):5. doi: 10.1186/s12875-019-1073-x
- Cunningham A, Shirley A. Mindlines in a digital age. Educ Primary Care. 2015;26(5):293–296. doi: 10.1080/14739879.2015.1079010
- Wieringa S, Greenhalgh T. 10 years of mindlines: a systematic review and commentary. Implement Sci. 2015;10(1):45. doi: 10.1186/s13012-015-0229-x
- Gabbay J, le May J. Mindlines: making sense of evidence in practice (Ed). Br J Gen Pract. 2016;66(649):402–403. doi: 10.3399/bjgp16X686221
- Launer J. Guidelines and Mindlines. Postgrad Med J. 2015;91(1081):663–664. doi: 10.1136/postgradmedj-2015-133766
- Lumlertgul N, Pityaratstian N, Wangsaturaka D. Cinemeducation: A pilot student project using movies to help students learn medical professionalism. Medical Teacher. 2009 July;31(7):e327–e332. doi: 10.1080/01421590802637941
- Disney+ Production Company, 2021. https://www.disneyplus.com
- Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302:123.
- US General Accounting Office. Prescription drugs: OxyContin abuse and diversion and efforts to address the problem. Report to Congressional Requesters. www.gao.gov/cgi-bin/getrpt?GAO-04-110.
- Van Zee A. The promotion and marketing of OxyContin: commercial triumph, public health tragedy. Am J Public Health. 2009 February;99(2):221–227. doi:10.2105/AJPH.2007.131714
- Ryan H, Girion L, Glover S. You want a description of hell?’Oxycontin’s 12-Hour Problem. https://www.latimes.com/projects/oxycontin-part1/#:~:text=In%20study%20after%20study%2C%20many,FDA%20analysis%20of%20the%20study
- Kolodny A. How FDA failures contributed to the opioid crisis. AMA Journal Of Ethics August. 2020;22(8):E743–750.
- Anon. Opioid overdose crisis: time for a radical rethink. Lancet Public Health. 2022 Mar;7(3):e195. DOI:10.1016/S2468-2667(22)00043-3
- National Institute on Drug Abuse. Drug Overdose Death Rates (Figure 1). https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates#:~:text=Drug%20overdose%20deaths%20involving%20any,among%20males%20(Figure%203)%20 accessed 20 may 2023
- US Food and Drug Administration Timeline of selected FDA activities and significant events addressing substance use and overdose prevention. Chronological information about significant FDA activities related to substance use and overdose prevention. https://www.fda.gov/drugs/information-drug-class/timeline-selected-fda-activities-and-significant-events-addressing-substance-use-and-overdose#:~:text=At%20the%20time%20of%20approval,high%20that%20would%20promote%20abuse
- Knauth D, Stempel J, Hals T. Sacklers to pay $6 billion to settle Purdue opioid lawsuits. Reuters March 2022. https://www.reuters.com/business/healthcare-pharmaceuticals/sacklers-will-pay-up-6-bln-resolve-purdue-opioid-lawsuits-mediator-2022-03-03/
- Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Sympt Manage. 2003;26(5):1026–1048.